一、干细胞移植治疗心肌梗死现状冠心病是全球重大健康问题,造成了巨大的疾病负担。作为西方国家主要死亡原因,冠心病在我国的发病率与死亡率逐年升高。近年来在西方发达同家,急性心肌梗死患者的死亡率有所降低,主要归功于血管再通治疗的应用,尤其是梗死相关动脉的早期再灌注。主要方法有经皮冠脉介入(PCI),药物溶栓治疗以及外科冠状动脉旁路移植术(CABG)。此外,支持治疗也充分控制了致死性心律失常,防 First, the status of stem cell transplantation for the treatment of myocardial infarction Coronary heart disease is a major global health problem, resulting in a huge burden of disease. As the main cause of death in Western countries, the incidence and mortality of coronary heart disease in our country have been increasing year by year. In recent years, there has been a decrease in the mortality rate among well-known domestic and western patients with acute myocardial infarction, which is mainly due to the application of revascularization therapy, especially the early reperfusion of infarct-related arteries. The main methods are percutaneous coronary intervention (PCI), drug thrombolysis and surgical coronary artery bypass grafting (CABG). In addition, supportive care is also sufficient control of lethal arrhythmia, prevention